T Yokoi

Nicotine metabolism and CYP2A6 allele frequencies in Koreans.

T Yamamoto, H. Yamazaki, M. Nakajima, 2001, Pharmacogenetics.

Co-operative regulation of the transcription of human dihydrodiol dehydrogenase (DD)4/aldo-keto reductase (AKR)1C4 gene by hepatocyte nuclear factor (HNF)-4alpha/gamma and HNF-1alpha.

T. Kamataki, Y. Takahashi, A. Hara, 2001, The Biochemical journal.

Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes.

H. Yamazaki, M. Nakajima, T. Yokoi, 1999, Drug metabolism and disposition: the biological fate of chemicals.

Involvement of microsomal cytochrome P450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver.

H. Yamazaki, M. Nakajima, T. Yokoi, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions.

H. Yamazaki, M. Nakajima, T. Yokoi, 2000, British journal of clinical pharmacology.

Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats.

M Nomura, T. Kamataki, T. Yokoi, 1996, Cancer research.

Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate.

H. Yamazaki, M. Nakajima, T. Yokoi, 2001, Drug metabolism and disposition: the biological fate of chemicals.

Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes.

H. Yamazaki, M. Nakajima, T. Yokoi, 2000, Drug metabolism and disposition: the biological fate of chemicals.